June 2017

Handa Pharmaceuticals Announces TruPharma’s U.S. Launch Of Its FDA-Approved ANDA for Lamotrigine Extended Release Tablets

May 2017

Handa Pharmaceuticals, Inc. Announces FDA Approval for Generic Version of AstraZeneca’s SEROQUEL XR® Extended Release Tablets

December 2016

Emerging Markets listing in Taiwan

November 2016

Taiwan Authorities Approve Public Issuance of Handa Stock

Handa Pharmaceuticals Announces Endo Begins Shipping Generic Version of AstraZeneca’s SEROQUEL XR®

May 2016

Pharmira Laboratories, Inc. Renamed Handa Pharmaceuticals, Inc.

February 2016

Pharmira Laboratories, Inc. Merges With Handa Pharmaceuticals, LLC

April 2015

Pharmira Laboratories, Inc. Approved as a Biotech & New Pharmaceutical Company

July 2014

Dexlansoprazole Patent Litigation Settled

May 2014

Pharmira Laboratories, Inc. founded in Taiwan

December 2013

Handa Pharmaceuticals Announces Tentative Approval of First-to-File ANDA for Takeda’s DEXILANT®

August 2013

Partner Launches Quetiapine XR in Canada

June 2013

ANDA for Lamotrigine XR approved by FDA

October 2012

Handa Pharmaceuticals Announces Acquisition and License Agreement with Par Pharmaceutical for Its First-to-File ANDA for AstraZeneca’s SEROQUEL XR®

April 2012

Handa Pharmaceuticals Announces Acquisition and License Agreement with Par Pharmaceutical for Its First-to-File ANDA for Takeda’s DEXILANT®

December 2011

Entered Marketing Partnership for Sitagliptin/Metformin

October 2011

Handa Pharmaceuticals Announces Patent Litigation Settlement With AstraZeneca On its First-to-File ANDA for SEROQUEL XR®

April 2011

Lamotrigine XR ANDA Filed

March 2011

Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takeda’s DEXILANT®

Entered Marketing Partnership for Quetiapine XR in Canada

December 2010

Handa Pharmaceuticals Announces Tentative Approval of its First-to-File ANDA for AstraZeneca’s SEROQUEL XR®

April 2010

Marketing Partner Files ANDA for Bupropion HBr

April 2009

Entered Marketing Partnership for Bupropion HBr

July 2008

Handa Pharmaceuticals Announces Submission of its First-to-File ANDA for AstraZeneca’s SEROQUEL® XR

September 2007

Hangzhou Handa Pharmaceutical Technology Co., Ltd. Subsidiary Established in China

November 2005

Handa Pharmaceuticals, LLC founded in Fremont, CA

Investment History
News